Scinai Immunotherapeutics (SCNI) Selling, General & Administrative (2014 - 2026)

Scinai Immunotherapeutics (SCNI) Selling, General & Administrative (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - -10.08 Mn
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn - 2.17 Mn
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 63.44 Bn 63.44 Bn - 17.02 Mn
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn 1.13 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 322.55 Mn
10 Scinai Immunotherapeutics 3.62 Bn 502.91 Mn -1.12 Mn -721,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -721,000.00
Jun 30, 2025 -755,000.00
Mar 31, 2025 -501,000.00
Dec 31, 2024 4.29 Mn
Sep 30, 2024 -764,000.00
Jun 30, 2024 -1.49 Mn
Mar 31, 2024 484,000.00
Dec 31, 2023 7.81 Mn
Sep 30, 2023 -968,000.00
Jun 30, 2023 1.14 Mn
Mar 31, 2023 1.19 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 967,000.00
Jun 30, 2022 1.29 Mn
Mar 31, 2022 1.45 Mn
Dec 31, 2021 -9.58 Mn
Sep 30, 2021 6.20 Mn
Jun 30, 2021 7.00 Mn
Mar 31, 2021 1.20 Mn
Dec 31, 2020 4.26 Mn